Clinical Challenges
Clinical Challenges
Significant variation in treatment response
Patients exhibit significant variability in drug response, requiring personalized treatment strategies and biomarker guidance.
Diseases are complex and highly heterogeneous
Neurological diseases often have diverse etiologies and complex clinical manifestations, making diagnosis and treatment challenging.
Early diagnosis is difficult
Many neurodegenerative and immune diseases lack clear early markers, leading to delayed treatment.
Challenging tracking and prognosis assessment
The lack of effective biomarkers to monitor disease progression and treatment efficacy impacts long-term management.
Key Assessment Areas
Key Assessment Areas
Parkinson's disease
Analyze neurological function and inflammation markers to assist in disease diagnosis and treatment strategy development.
Neuroinflammation and Autoimmune Diseases
Analyzing immune regulation and inflammatory responses to provide a basis for precise diagnosis and treatment.
Multiple Sclerosis
Monitor immune activity and neural damage markers to assess disease activity and treatment response.
Epilepsy
Assess biomarkers of neuroinflammation and neuronal function to facilitate disease monitoring and personalized treatment.
Alzheimer's disease
Evaluate neurodegenerative biomarkers to assist in early detection, disease staging, and treatment monitoring.
Amyotrophic Lateral Sclerosis (ALS)
Analysis of neuronal damage and disease progression indicators supports prognostic assessment and clinical management.
Cell and Biomarker Analysis
Biomarker Analysis
Neural Injury and Degeneration Markers
- Neurofilament protein
- Glial Fibrillary Acidic Protein
- Tau / Phosphorylated Tau
- Amyloid-beta
- Cytokine detection
Nerve Cell Related
- Neuron
- Astrocyte
- Oligodendrocyte
- Microglia
- Neural Progenitor Cell
Immunity and Inflammation-related
- T Cells
- B Cells
- Natural Killer Cells (NK Cells)
- Dendritic Cells (DCs)
- Cytokine Analysis
Testing Workflow
Workflow
Sample Collection
Sample Processing and Separation
Flow Cytometry Testing
AI Smart Analysis
AI Cell Report
Clinical Decision Support
Clinical Applications
Clinical Applications
Neurodegenerative Disease Research
Exploring disease mechanisms and biomarkers for conditions like Alzheimer's and Parkinson's.
Biomarker Development
Develop biomarkers for early diagnosis and prognostic assessment.
Drug Development and Efficacy Evaluation
Evaluate the effects of drugs on nerve cells and immune cells.
Immune and Inflammatory Mechanisms Research
Analyze neuroimmune responses and inflammatory pathways to identify therapeutic targets.